Source:http://linkedlifedata.com/resource/pubmed/id/19878656
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2009-11-30
|
pubmed:abstractText |
Mutations of the leucine-rich repeat kinase 2 (LRRK2) gene are the leading cause of genetically inherited Parkinson's disease (PD) and its more severe variant diffuse Lewy body disease (DLB). Pathological mutations in Lrrk2 are autosomal dominant, suggesting a gain of function. Mutations in alpha-synuclein also produce autosomal dominant disease. Here we report an interaction between Lrrk2 and alpha-synuclein in a series of diffuse Lewy body (DLB) cases and in an oxidative stress cell based assay. All five cases of DLB, but none of five controls, showed co-immunoprecipitation of Lrrk2 and alpha-synuclein in soluble brain extracts. Colocalization was also found in pathological deposits in DLB postmortem brains by double immunostaining. In HEK cells transfected simultaneously with plasmids expressing Lrrk2 and alpha-synuclein, co-immunoprecipitation of Lrrk2 and alpha-synuclein was detected when they were exposed to oxidative stress by H(2)O(2). Taken together, these results suggest the possibility that in PD and related synucleinopathies, oxidative stress upregulates alpha-syn and Lrrk2 expression, paving the way for pathological interactions. New therapeutic approaches to PD and the synucleinopathies may result from limiting the interaction between Lrrk2 and alpha-synuclein.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1090-2104
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
25
|
pubmed:volume |
390
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1229-34
|
pubmed:meshHeading |
pubmed-meshheading:19878656-Brain,
pubmed-meshheading:19878656-Cell Line,
pubmed-meshheading:19878656-Humans,
pubmed-meshheading:19878656-Immunoprecipitation,
pubmed-meshheading:19878656-Lewy Body Disease,
pubmed-meshheading:19878656-Oxidative Stress,
pubmed-meshheading:19878656-Protein-Serine-Threonine Kinases,
pubmed-meshheading:19878656-RNA, Messenger,
pubmed-meshheading:19878656-alpha-Synuclein
|
pubmed:year |
2009
|
pubmed:articleTitle |
Lrrk2 interaction with alpha-synuclein in diffuse Lewy body disease.
|
pubmed:affiliation |
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|